Diabetic Eye Disease

Latest News

Image Credit: © Seventyfour - stock.adobe.com
Alimera completes recruitment for its NEW DAY study

May 25th 2023

According to the company, the study has now reached its goal of 300 patients enrolled to evaluate ILUVIEN as a first line, baseline therapy for DME.

This week in optometry: March 20-March 24
This week in optometry: March 20-March 24

March 25th 2023

Do diabetes, diabetic retinal disease contribute to macular degeneration?
Do diabetes, diabetic retinal disease contribute to macular degeneration?

March 21st 2023

row of syringes of aflibercept
Regeneron receives FDA acceptance, priority review of BLA for aflibercept 8 mg for wet AMD and DME

February 23rd 2023

Surprising findings from the DRCR Retina Network Protocol AA
Surprising findings from the DRCR Retina Network Protocol AA

January 23rd 2023

Video Series
Video Interviews
Podcasts
Dr. Kerry Gelb speaks with Dr. Jay M. Hainie in the second part of their discussion on diabetes of the eye!
Open Your Eyes with Dr Kerry Gelb featuring Dr. Jay Haynie in "diabetes of the eye"
Latest CME Events & Activities

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

C.R.U. Eye Symposium (Current, Relevant, Useful)

11/10/2023-11/12/2023

View More

C.R.U. Eye Symposium (Current, Relevant, Useful)

11/10/2023-11/12/2023

View More

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

View More

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

View More

Shared Perspectives in Managing Presbyopia – Understanding a New Paradigm for Optimizing Quality of Life

View More

Shared Perspectives in Managing Presbyopia – Understanding a New Paradigm for Optimizing Quality of Life

View More

(CME Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

(CME Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

The Optometry Times EyeCon 2023

View More

Perfecting Co-Management of Glaucoma – Utilizing Development in the Spectrum of Treatment Options

View More

Perfecting Co-Management of Glaucoma – Utilizing Development in the Spectrum of Treatment Options

View More

Expert Insights in Geographic Atrophy with Transformative Care on the Horizon – Understanding the Complement System as a Target for Treatment

View More

Expert Insights in Geographic Atrophy with Transformative Care on the Horizon – Understanding the Complement System as a Target for Treatment

View More

(COPE Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

(COPE Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

(COPE Credit) Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED

View More

More News

© 2023 MJH Life Sciences

All rights reserved.